Angiotensin II type 1 receptor binding molecule ATRAP as a possible modulator of renal sodium handling and blood pressure in pathophysiology

Current Medicinal Chemistry

Volumn 22, Issue 28, 2015, Pages 3210-3216

  Tamura, K ^a   Wakui, H ^a   Azushima, K ^a   Uneda, K ^a   Haku, S ^a   Kobayashi, R ^a   Ohki, K ^a   Haruhara, K ^a   Kinguchi, S ^a   Matsuda, M ^a   Yamashita, A ^a   Umemura, S ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; Hypertension; Kidney; Receptor; Renal disease; Sodium reabsorption

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II TYPE 1 RECEPTOR PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SODIUM;

ARTICLE; BLOOD PRESSURE REGULATION; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA LIBRARY; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; INTERNALIZATION; KIDNEY DEVELOPMENT; KIDNEY EPITHELIUM; KIDNEY TUBULE ABSORPTION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; BINDING SITE; BLOOD PRESSURE; CHEMISTRY; GENETICS; KIDNEY; METABOLISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BINDING SITES; BLOOD PRESSURE; HUMANS; KIDNEY; RECEPTOR, ANGIOTENSIN, TYPE 1; SODIUM;

EID: 84945246348     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150821095036     Document Type: Article

References (36)

1. Kamo, T.; Akazawa, H.; Komuro, I. Pleiotropic effects of angiotensin ii receptor signaling in cardiovascular homeostasis and aging. Int. Heart J., 2015, 56(3), 249-254.
2. Horiuchi, M.; Iwanami, J.; Mogi, M. Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci (Lond), 2012, 123(4), 193-203.
3. Nishida, M.; Ogushi, M.; Suda, R.; Toyotaka, M.; Saiki, S.; Kitajima, N.; Nakaya, M.; Kim, K.M.; Ide, T.; Sato, Y.; Inoue, K.; Kurose, H. Heterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-kappaB. Proc. Natl. Acad. Sci. USA, 2011, 108(16), 6662-6667.
4. Bellot, M.; Galandrin, S.; Boularan, C.; Matthies, H.J.; Despas, F.; Denis, C.; Javitch, J.; Mazeres, S.; Sanni, S.J.; Pons, V.; Seguelas, M.H.; Hansen, J.L.; Pathak, A.; Galli, A.; Senard, J.M.; Gales, C. Dual agonist occupancy of AT1-R-alpha2C-AR heterodimers results in atypical Gs-PKA signaling. Nat. Chem. Biol., 2015, 11(4), 271-279.
5. Balakumar, P.; Jagadeesh, G. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology. Cell Signal., 2014, 26(10), 2147-2160.
6. Cabana, J.; Holleran, B.; Leduc, R.; Escher, E.; Guillemette, G.; Lavigne, P. Identification of distinct conformations of the angiotensin-II type 1 receptor associated with the Gq/11 protein pathway and the beta-arrestin pathway using molecular dynamics simulations. J. Biol. Chem., 2015, 290(25), 15835-15854.
7. Miura, S.; Fujino, M.; Hanzawa, H.; Kiya, Y.; Imaizumi, S.; Matsuo, Y.; Tomita, S.; Uehara, Y.; Karnik, S.S.; Yanagisawa, H.; Koike, H.; Komuro, I.; Saku, K. Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. J. Biol. Chem., 2006, 281(28), 19288-19295.
8. Mehta, P.K.; Griendling, K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol., 2007, 292(1), C82-97.
9. Aplin, M.; Bonde, M.M.; Hansen, J.L. Molecular determinants of angiotensin II type 1 receptor functional selectivity. J. Mol. Cell Cardiol., 2009, 46, (1), 15-24.
10. Violin, J.D.; Crombie, A.L.; Soergel, D.G.; Lark, M.W. Biased ligands at G-protein-coupled receptors: promise and progress. Trends Pharmacol. Sci., 2014, 35(7), 308-316.
11. Cook, J.L.; Re, R.N.; deHaro, D.L.; Abadie, J.M.; Peters, M.; Alam, J. The trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor. Circ. Res., 2008, 102(12), 1539-1547.
12. Garner, K.; Li, M.; Ugwuanya, N.; Cockcroft, S. The phosphatidylinositol transfer protein RdgBbeta binds 14-3-3 via its unstructured C-terminus, whereas its lipid-binding domain interacts with the integral membrane protein ATRAP (angiotensin II type I receptor-associated protein). Biochem. J., 2011, 439, (1), 97-111.
13. Doblinger, E.; Hocherl, K.; Mederle, K.; Kattler, V.; Walter, S.; Hansen, P.B.; Jensen, B.; Castrop, H. Angiotensin AT1 receptor-associated protein Arap1 in the kidney vasculature is suppressed by angiotensin II. Am. J. Physiol. Renal Physiol., 2012, 302(10), F1313-1324.
14. Mogi, M.; Iwai, M.; Horiuchi, M. Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler. Thromb. Vasc. Biol., 2007, 27(12), 2532-2539.
15. Tamura, K.; Tanaka, Y.; Tsurumi, Y.; Azuma, K.; Shigenaga, A.; Wakui, H.; Masuda, S.; Matsuda, M. The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function. Curr. Hypertens Rep., 2007, 9(2), 121-127.
16. Tamura, K.; Wakui, H.; Maeda, A.; Dejima, T.; Ohsawa, M.; Azushima, K.; Kanaoka, T.; Haku, S.; Uneda, K.; Masuda, S.I.; Azuma, K.; Shigenaga, A.I.; Koide, Y.; Tsurumi-Ikeya, Y.; Matsuda, M.; Toya, Y.; Tokita, Y.; Yamashita, A.; Umemura, S. The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap. Curr. Pharm. Des., 2013, 19(17), 3043-3048.
17. Mehta, P.K.; Griendling, K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol., 2007, 292(1), C82-97.
18. Zhang, H.; Unal, H.; Gati, C.; Han, G.W.; Liu, W.; Zatsepin, N.A.; James, D.; Wang, D.; Nelson, G.; Weierstall, U.; Sawaya, M.R.; Xu, Q.; Messerschmidt, M.; Williams, G.J.; Boutet, S.; Yefanov, O.M.; White, T.A.; Wang, C.; Ishchenko, A.; Tirupula, K.C.; Desnoyer, R.; Coe, J.; Conrad, C.E.; Fromme, P.; Stevens, R.C.; Katritch, V.; Karnik, S.S.; Cherezov, V. Structure of the Angiotensin receptor revealed by serial femtosecond crystallography. Cell, 2015, 161(4), 833-844.
19. Daviet, L.; Lehtonen, J.Y.; Tamura, K.; Griese, D.P.; Horiuchi, M.; Dzau, V.J. Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J. Biol. Chem., 1999, 274(24), 17058-17062.
20. Wang, W.; Huang, Y.; Zhou, Z.; Tang, R.; Zhao, W.; Zeng, L.; Xu, M.; Cheng, C.; Gu, S.; Ying, K.; Xie, Y.; Mao, Y. Identification and characterization of AGTRAP, a human homolog of murine Angiotensin II Receptor-Associated Protein (Agtrap). Int. J. Biochem. Cell. Biol., 2002, 34(1), 93-102.
21. Lopez-Ilasaca, M.; Liu, X.; Tamura, K.; Dzau, V.J. The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol. Biol. Cell, 2003, 14(12), 5038-5050.
22. Tanaka, Y.; Tamura, K.; Koide, Y.; Sakai, M.; Tsurumi, Y.; Noda, Y.; Umemura, M.; Ishigami, T.; Uchino, K.; Kimura, K.; Horiuchi, M.; Umemura, S. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy. FEBS Lett., 2005, 579(7), 1579-1586.
23. Azuma, K.; Tamura, K.; Shigenaga, A.; Wakui, H.; Masuda, S.; Tsurumi-Ikeya, Y.; Tanaka, Y.; Sakai, M.; Matsuda, M.; Hashimoto, T.; Ishigami, T.; Lopez-Ilasaca, M.; Umemura, S. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. Hypertension, 2007, 50(5), 926-932.
24. Tsurumi, Y.; Tamura, K.; Tanaka, Y.; Koide, Y.; Sakai, M.; Yabana, M.; Noda, Y.; Hashimoto, T.; Kihara, M.; Hirawa, N.; Toya, Y.; Kiuchi, Y.; Iwai, M.; Horiuchi, M.; Umemura, S. Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules. Kidney Int., 2006, 69(3), 488-494.
25. Maeda, A.; Tamura, K.; Wakui, H.; Dejima, T.; Ohsawa, M.; Azushima, K.; Kanaoka, T.; Uneda, K.; Matsuda, M.; Yamashita, A.; Miyazaki, N.; Yatsu, K.; Hirawa, N.; Toya, Y.; Umemura, S. Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity. J. Am. Heart Assoc., 2013, 2(4), e000312.
26. Ohsawa, M.; Tamura, K.; Wakui, H.; Maeda, A.; Dejima, T.; Kanaoka, T.; Azushima, K.; Uneda, K.; Tsurumi-Ikeya, Y.; Kobayashi, R.; Matsuda, M.; Uchida, S.; Toya, Y.; Kobori, H.; Nishiyama, A.; Yamashita, A.; Ishikawa, Y.; Umemura, S. Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension. Kidney Int., 2014, 86(3), 570-581.
27. Masuda, S.; Tamura, K.; Wakui, H.; Maeda, A.; Dejima, T.; Hirose, T.; Toyoda, M.; Azuma, K.; Ohsawa, M.; Kanaoka, T.; Yanagi, M.; Yoshida, S.; Mitsuhashi, H.; Matsuda, M.; Ishigami, T.; Toya, Y.; Suzuki, D.; Nagashima, Y.; Umemura, S. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy. Am. J. Physiol. Renal Physiol., 2010, 299(4), F720-F731.
28. Friedman, P.A.; Gesek, F.A. Stimulation of calcium transport by amiloride in mouse distal convoluted tubule cells. Kidney Int., 1995, 48(5), 1427-1434.
29. Gesek, F.A.; Friedman, P.A. Sodium entry mechanisms in distal convoluted tubule cells. Am. J. Physiol., 1995, 268(1 Pt 2), F89-98.
30. Kobori, H.; Nangaku, M.; Navar, L.G.; Nishiyama, A. The intrarenal Renin-Angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev., 2007, 59(3), 251-287.
31. Dejima, T.; Tamura, K.; Wakui, H.; Maeda, A.; Ohsawa, M.; Kanaoka, T.; Haku, S.; Kengo, A.; Masuda, S.; Shigenaga, A.; Azuma, K.; Matsuda, M.; Yabana, M.; Hirose, T.; Uchino, K.; Kimura, K.; Nagashima, Y.; Umemura, S. Prepubertal angiotensin blockade exerts longterm therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats. J. Hypertens., 2011, 29(10), 1919-1929.
32. Wakui, H.; Tamura, K.; Matsuda, M.; Bai, Y.; Dejima, T.; Shigenaga, A.; Masuda, S.; Azuma, K.; Maeda, A.; Hirose, T.; Ishigami, T.; Toya, Y.; Yabana, M.; Minamisawa, S.; Umemura, S. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice. Am. J. Physiol. Renal Physiol., 2010, 299(5), F991-F1003.
33. Wakui, H.; Tamura, K.; Masuda, S.; Tsurumi-Ikeya, Y.; Fujita, M.; Maeda, A.; Ohsawa, M.; Azushima, K.; Uneda, K.; Matsuda, M.; Kitamura, K.; Uchida, S.; Toya, Y.; Kobori, H.; Nagahama, K.; Yamashita, A.; Umemura, S. Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension, 2013, 61(6), 1203-1210.
34. Giani, J.F.; Fuchs, S.; Gonzalez-Villalobos, R.A. Angiotensin II type 1 receptor-associated protein: a novel modulator of angiotensin II actions in the nephron. Hypertension, 2013, 61(6), 1150-1152.
35. Matsuda, M.; Tamura, K.; Wakui, H.; Dejima, T.; Maeda, A.; Ohsawa, M.; Kanaoka, T.; Haku, S.; Azushima, K.; Yamasaki, H.; Saito, D.; Hirose, T.; Maeshima, Y.; Nagashima, Y.; Umemura, S. Involvement of Runx3 in the basal transcriptional activation of the mouse angiotensin II type 1 receptor-associated protein gene. Physiol. Genomics, 2011, 43(14), 884-894.
36. Matsuda, M.; Tamura, K.; Wakui, H.; Maeda, A.; Ohsawa, M.; Kanaoka, T.; Azushima, K.; Uneda, K.; Haku, S.; Tsurumi-Ikeya, Y.; Toya, Y.; Maeshima, Y.; Yamashita, A.; Umemura, S. Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein. J. Biol. Chem., 2013, 288(26), 19238-19249.